Quick Answer
Benitec Biopharma Inc. reported Total Revenue of $59.0 thousand for fiscal year 2021.
Benitec Biopharma Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2021 | $59.0K | -42.2% |
| 2020 | $102.0K | -99.2% |
| 2019 | $12.20M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.00 | — | — |
| September 30, 2025 | $0.00 | — | — |
| March 31, 2025 | $0.00 | — | — |
| December 31, 2024 | $0.00 | — | — |
| September 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | -100.0% | — |
| December 31, 2023 | $0.00 | -100.0% | — |
| September 30, 2023 | $0.00 | — | -100.0% |
- Benitec Biopharma Inc. showed a decrease of -42.2% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2021 period, Benitec Biopharma Inc.’s total revenue has declined by 99.5% (from $12.20 million to $59.0 thousand).
- The most recent figure is from Benitec Biopharma Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on September 20, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: